AZGP1 Protein Expression in Hormone-Naïve Advanced Prostate Cancer Treated with Primary Androgen Deprivation Therapy

Biomarkers for predicting the risk of castration-resistant prostate cancer (CRPC) in men treated with primary androgen deprivation therapy (ADT) are lacking. We investigated whether Zinc-alpha 2 glycoprotein (AZGP1) expression in the diagnostic biopsies of men with hormone-naïve prostate cancer (PCa...

Descripción completa

Detalles Bibliográficos
Autores principales: Winther, Mads Dochedahl, Kristensen, Gitte, Stroomberg, Hein Vincent, Berg, Kasper Drimer, Toft, Birgitte Grønkær, Brooks, James D., Brasso, Klaus, Røder, Martin Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460336/
https://www.ncbi.nlm.nih.gov/pubmed/32726925
http://dx.doi.org/10.3390/diagnostics10080520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460336/
https://www.ncbi.nlm.nih.gov/pubmed/32726925
http://dx.doi.org/10.3390/diagnostics10080520

Ejemplares similares